12.82USD-1.72%Mkt Cap: 178.17M USDP/E: —Last update: 2026-05-26
Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development …
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap178.17M USD
Enterprise Value-18.94M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-97.17M USD
Revenue/Share—
Last Price12.82 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees92
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS4525EP1011
Valuation
P/E (Trailing)—
P/E (Forward)-3.10
PEG—
EV/EBITDA0.17
EV/Revenue—
P/S—
P/B-22.20
EPS (TTM)-4.77
EPS (Forward)-3.97
52W Range
5.06077% of range15.10
52W High15.10 USD
52W Low5.060 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE1456.20%
ROA-404.01%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-85.81M USD
CapEx (TTM)161.00K USD
FCF Margin—
FCF Yield-24.44%
Net Debt-186.48M USD
Net Debt/EBITDA1.70
Balance Sheet
Debt/Equity-0.09
Current Ratio4.92
Quick Ratio4.87
Book Value/Sh-0.5540 USD
Cash/Share13.70 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateApr 15, 2019
Splits
Last Split1:10
Split DateApr 27, 2026
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)47.13 USD
Target Range19.00 USD – 85.00 USD
# Analysts8
Ownership
Shares Out.13.62M
Float10.49M
Insiders0.97%
Institutions44.49%
Short Interest
Short Ratio4.3d
Short % Float9.91%
Short % Out.9.81%
Shares Short1.34M
Short (prev mo.)895.47K
Technical
SMA 5011.29 (+13.6%)
SMA 2008.764 (+46.3%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)320.97K
Avg Vol (10d)217.87K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—